Where does Neonatal Product Group, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neonatal Product Group, Inc. ranks #32,605 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neonatal Product Group, Inc. hold?

Neonatal Product Group, Inc. holds 8 US utility patents granted between 2016 and 2022, spanning 8 technology areas.

What is Neonatal Product Group, Inc.'s Innovation Score?

Neonatal Product Group, Inc. has an Innovation Score of 27.9 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Neonatal Product Group, Inc.'s patent grant rate increasing or decreasing?

Neonatal Product Group, Inc.'s recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Neonatal Product Group, Inc.'s patents?

Neonatal Product Group, Inc.'s patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neonatal Product Group, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neonatal Product Group, Inc.

Q: What technology areas does Neonatal Product Group, Inc. focus on?

Neonatal Product Group, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neonatal ranks #32,605 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#32,605
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.9/100): 15.0
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32605 · US Corporation #32,605 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,605/49,997
PHOTO-FINISH Navigo Proteins
CPC-NARROW A61M · 8 areas
INNOV-THIN 27.9/100
CLAIMS-RICH 15.0 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Navigo Proteins GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Neonatal Product Group · this assignee

28
3D Lighting… · lowest

7

What this shows Neonatal's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Neonatal's grants concentrate

Neonatal Product Group, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 75% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2016. By volume, Neonatal sits between Navigo Proteins GmbH and NeuroEnterprises, LLC.

Neonatal's three-year grant acceleration

Neonatal Product Group, Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Navigo Proteins

8
Navinfo Europe B V

8
Nei &

8
Neomed Institute

8
Neos Therapeutics

8
Neureality

8
Neuralytix

8
Neuroenterprises

8
Neonatal Product… ◀

8

What this shows Neonatal holds 8 patents at rank #32,654, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neonatal

By rank, the assignees closest to #32,654 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Neonatal's primary technology class.

Neonatal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Neonatal Product Group, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	12.5%
2018	1	12.5%
2019	3	37.5%
2020	1	12.5%
2021	1	12.5%
2022	1	12.5%

Which technologies does Neonatal Product Group, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61B - DIAGNOSIS; SURGERY; Identification 4

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A47B - TABLES; DESKS; Office FURNITURE; CABINETS; DRAWERS; General Details OF Furniture 2

G01G - Weighing 2

E05B - LOCKS; Accessories THEREFOR; Handcuffs 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#32,605

of 49,997 tracked assignees

Innovation Score

27.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Neonatal Product Group, Inc.'s patent record in context - here's where to go next.

Neonatal Product Group, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 75% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #32,605 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neonatal Product Group, Inc. against Navigo Proteins GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.